Segui
Elena Catanzaro
Elena Catanzaro
Ugent
Email verificata su unibo.it
Titolo
Citata da
Citata da
Anno
Vaccination with early ferroptotic cancer cells induces efficient antitumor immunity
I Efimova, E Catanzaro, L Van der Meeren, VD Turubanova, H Hammad, ...
Journal for immunotherapy of cancer 8 (2), 2020
2512020
Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine
VD Turubanova, IV Balalaeva, TA Mishchenko, E Catanzaro, R Alzeibak, ...
Journal for immunotherapy of cancer 7, 1-13, 2019
2052019
Marine sponge natural products with anticancer potential: An updated review
C Calcabrini, E Catanzaro, A Bishayee, E Turrini, C Fimognari
Marine drugs 15 (10), 310, 2017
1592017
Ellagitannins in cancer chemoprevention and therapy
T Ismail, C Calcabrini, AR Diaz, C Fimognari, E Turrini, E Catanzaro, ...
Toxins 8 (5), 151, 2016
1192016
The potential effects of Ocimum basilicum on health: a review of pharmacological and toxicological studies
P Sestili, T Ismail, C Calcabrini, M Guescini, E Catanzaro, E Turrini, ...
Expert Opinion on Drug Metabolism & Toxicology 14 (7), 679-692, 2018
982018
Cold atmospheric plasma induces apoptosis and oxidative stress pathway regulation in T-lymphoblastoid leukemia cells
E Turrini, R Laurita, A Stancampiano, E Catanzaro, C Calcabrini, F Maffei, ...
Oxidative medicine and cellular longevity 2017, 2017
752017
Natural Products to Fight Cancer: A Focus on Juglans regia
E Catanzaro, G Greco, L Potenza, C Calcabrini, C Fimognari
Toxins 10 (11), 469, 2018
612018
Nrf2: a potential therapeutic target for naturally occurring anticancer drugs?
E Catanzaro, C Calcabrini, E Turrini, P Sestili, C Fimognari
Expert opinion on therapeutic targets 21 (8), 781-793, 2017
472017
Natural products as inducers of non-canonical cell death: a weapon against cancer
G Greco, E Catanzaro, C Fimognari
Cancers 13 (2), 304, 2021
452021
Anticancer potential of allicin: A review
E Catanzaro, D Canistro, V Pellicioni, F Vivarelli, C Fimognari
Pharmacological research 177, 106118, 2022
412022
Antitumor potential of marine and freshwater lectins
E Catanzaro, C Calcabrini, A Bishayee, C Fimognari
Marine drugs 18 (1), 11, 2019
402019
Withania somnifera Induces Cytotoxic and Cytostatic Effects on Human T Leukemia Cells
E Turrini, C Calcabrini, P Sestili, E Catanzaro, E De Gianni, AR Diaz, ...
Toxins 8 (5), 147, 2016
382016
In Vitro Study of the Cytotoxic, Cytostatic, and Antigenotoxic Profile of Hemidesmus indicus (L.) R.Br. (Apocynaceae) Crude Drug Extract on T Lymphoblastic Cells
E Turrini, C Calcabrini, M Tacchini, T Efferth, G Sacchetti, A Guerrini, ...
Toxins 10 (2), 70, 2018
302018
Targeting topoisomerase II with trypthantrin derivatives: Discovery of 7-((2-(dimethylamino) ethyl) amino) indolo [2, 1-b] quinazoline-6, 12-dione as an antiproliferative agent …
E Catanzaro, N Betari, JM Arencibia, S Montanari, C Sissi, A De Simone, ...
European Journal of Medicinal Chemistry 202, 112504, 2020
252020
On a beam of light: Photoprotective activities of the marine carotenoids astaxanthin and fucoxanthin in suppression of inflammation and cancer
E Catanzaro, A Bishayee, C Fimognari
Marine drugs 18 (11), 544, 2020
242020
Marine anthraquinones: pharmacological and toxicological issues
G Greco, E Turrini, E Catanzaro, C Fimognari
Marine drugs 19 (5), 272, 2021
232021
Hemidesmus indicus induces immunogenic death in human colorectal cancer cells
E Turrini, E Catanzaro, MG Muraro, V Governa, E Trella, V Mele, ...
Oncotarget 9 (36), 24443, 2018
232018
Plasma‐activated medium as an innovative anticancer strategy: Insight into its cellular and molecular impact on in vitro leukemia cells
E Turrini, R Laurita, E Simoncelli, A Stancampiano, E Catanzaro, ...
Plasma Processes and Polymers 17 (10), 2000007, 2020
212020
Novel polyamine-based Histone deacetylases-Lysine demethylase 1 dual binding inhibitors
A Milelli, C Marchetti, E Turrini, E Catanzaro, R Mazzone, D Tomaselli, ...
Bioorganic & Medicinal Chemistry Letters 28 (6), 1001-1004, 2018
212018
Immunogenic cell death and role of nanomaterials serving as therapeutic vaccine for personalized cancer immunotherapy
E Catanzaro, O Feron, AG Skirtach, DV Krysko
Frontiers in immunology 13, 925290, 2022
202022
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20